Following are the notable stock gainers on the Nasdaq on Monday:-
Scopus Biopharma Inc (NASDAQ: SCPS) was the notable gainer and soared 72% after The approval has been awarded for the company’s product named CpG-STAT3siRNA, which is regarded as a distinct RNA meant for treating patients who may be suffering from cancers. The company announced that it is going to start a Phase 1 clinical trial of the product at City of Hope. n this trial, the product is going to be trialled as a treatment for B-cell non-Hodgkin lymphoma. Scopus is involved in the biopharmaceutical space and has been in the quest to produce innovative therapies.
MMA Capital Holdings Inc (NASDAQ: MMAC) stock surged 58% to $26.96 after the company announced that it has entered into a definitive merger agreement with an affiliate of Fundamental Advisors LP (together “Fundamental”), under which it will be acquired by Fundamental in an all-cash transaction valued at approximately $161.7 million (the “Merger Agreement”). Under the terms of the Merger Agreement, holders of MMA’s common stock will upon the closing of the merger receive $27.77 per share in cash. This represents a 35% premium over the 90-day volume-weighted average share price ending May 21, 2021, and a 62% premium over the May 21, 2021, closing share price.
Creative Realities Inc (NASDAQ: CREX) was up 47.33% to close at $1.93. Last week, The company posted a 35% year-over-year jump in revenue to $5.0 million. The company swung to a quarterly profit of $1.3 million, from a year-ago loss of $13.2 million. EBITDA was $2.4 million for the three months ended March 31, 2021, as compared to an EBITDA loss of $12.7 million in the same period in 2020.
Adjusted EBITDA was $0.7 million for the three months ended March 31, 2021, compared to an Adjusted EBITDA loss of $1.9 million for the same period in 2020. See below for a description of these non-GAAP financial measures and reconciliation to our net loss.
